Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
National Institutes of Health · Department of Health and Human Services
At a glance
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) is an open federal cooperative agreement opportunity from the National Institutes of Health (Department of Health and Human Services). Applications are due October 19, 2026. Individual awards are listed as $50K – $600K, with about 3 awards expected and $2.6M in total estimated funding. Applicant types listed as eligible include state governments, county governments, city or township governments, special district governments, independent school districts and 10 more. Cost sharing is not required. It is funded under Assistance Listing 93.393 (Cancer Cause and Prevention Research) and 4 other listings.
Summary assembled from the official notice's fields. The official notice governs.
Key facts
- May 21, 2026Posted
- Oct 19, 2026Application deadlinenext date
- Jul 1, 2026 (est.)Est. award date
- Dec 19, 2026Archived
- Posted
- May 21, 2026
- Close date
- Oct 19, 2026
- Archive date
- Dec 19, 2026
- Est. award date
- Jul 1, 2026
- Award floor
- $50,000
- Award ceiling
- $600,000
- Est. total funding
- $2,600,000
- Expected awards
- 3
- Cost sharing
- Not required
- Funding instrument
- Cooperative Agreement
- Opportunity category
- Discretionary
Who can apply
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public colleges & universities
- Federally recognized tribal governments
- Public & Indian housing authorities
- Native American tribal organizations
- 501(c)(3) nonprofits
- Nonprofits without 501(c)(3) status
- Private colleges & universities
- For-profit organizations (not small businesses)
- Small businesses
- Others (see notice)
Additional information on eligibility (from the notice)
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/Foreign Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
A quick check against the listed applicant types — other requirements in the notice still apply.
Based on the published notice. Review the official notice for complete eligibility requirements.
What it funds
Official synopsis as published by the agency, formatted for readability.
This Notice of Funding Opportunity (NOFO) invites applications for advanced development and enhancement of emerging informatics technologies to improve the acquisition, analysis, visualization, and interpretation of data across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology. As a component of the NCI's Informatics Technology for Cancer Research (ITCR) Program, this NOFO is focused on advancing emerging informatics technology, defined as one that has passed the initial prototyping and pilot development stage, has demonstrated potential to have a significant and broader impact, has compelling reasons for further improvement and enhancement, and has not been widely adopted in the cancer research field. To be successful, proposed development plans must have a clear rationale for why the proposed technology is needed and how it will benefit the cancer research field. In addition, mechanisms to solicit feedback from driving cancer research projects as well as the broader user community throughout the development process must be included.This NOFO invites applications for the enhancement and dissemination of emerging, user-friendly informatics technologies that support a wide range of cancer research, including discovery biology, population studies, as well as clinical and translational research. The emphasis is on uniqueness and potential impact on cancer research. In addition, all projects proposed in response to this NOFO must involve the following general attributes:Potential to advance driving cancer research projects and the cancer research field in general;Offers clear advantages over competing technologies in the targeted cancer research domain;Provides compelling plans and processes for supporting and engaging end users to evaluate and apply the tool or resource;Provides plans for advancing use of the tool or resource by the targeted community through collaboration, outreach, and training;Provides a realistic timeline and milestones for technology development.
Full announcement & documents
The full announcement has the complete rules — page limits, required attachments, evaluation criteria and any letter-of-intent dates. Files download directly from Grants.gov.
How to apply
0 of 8 done · progress saved in this browser
Assistance Listings
What is an ALN?- 93.393Cancer Cause and Prevention ResearchProgram →
- 93.394Cancer Detection and Diagnosis ResearchProgram →
- 93.395Cancer Treatment ResearchProgram →
- 93.396Cancer Biology ResearchProgram →
- 93.399Cancer ControlProgram →
Reported obligations under ALN 93.393
Historical data · not a predictionAgency contact (as published)
National Institutes of Health
nciitcr@mail.nih.gov
301-402-2541
Quick answers
When is the deadline for this opportunity?
According to the official notice, applications are due October 19, 2026. Confirm the deadline and submission time on Grants.gov before applying.
Who is eligible to apply for this opportunity?
The official notice lists these applicant types as eligible: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public colleges & universities, Federally recognized tribal governments, Public & Indian housing authorities, Native American tribal organizations, 501(c)(3) nonprofits, Nonprofits without 501(c)(3) status, Private colleges & universities and 3 more. Additional restrictions may apply; review the full notice.
How much funding is available through this opportunity?
Per the notice, individual awards are listed as $50k – $600k, total estimated program funding is $2,600,000 and the agency expects to make about 3 awards.
How do I apply for this opportunity?
Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity RFA-CA-27-020), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.
Related open opportunities
Matched on shared Assistance Listings, agency, categories and eligible applicant types.
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
National Institutes of Health- Award range
- $50K – $600K
- Closes
- Oct 19, 2026
- Who can apply
- State governments, County governments, City or township governments and 12 more
NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Nov 2, 2026 (est.)
- Who can apply
- State governments, County governments, City or township governments and 12 more
NCI Research Specialist Award for Core and Laboratory-based Scientists (R50 Clinical Trial Not Allowed)
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Nov 20, 2026 (est.)
- Who can apply
- State governments, County governments, City or township governments and 12 more
Advanced Development and Sustainment of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
National Institutes of Health- Award range
- Up to $600K
- Est. close
- Jun 11, 2027 (est.)
- Who can apply
- State governments, County governments, City or township governments and 12 more
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
National Institutes of Health- Award range
- $50K – $300K
- Closes
- Oct 19, 2027
- Who can apply
- State governments, County governments, City or township governments and 12 more
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
National Institutes of Health- Award range
- Amount not specified
- Closes
- Jan 7, 2028
- Who can apply
- State governments, County governments, City or township governments and 12 more